Pall has acquired 8 companies of its own, including 1 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 2 assets.
Pall’s largest acquisition to date was in 2014, when it acquired ATMI- LifeSciences Business for $185M. It’s largest disclosed sale occurred in 2012, when it sold Pall - Transfusion Medicine Business to Haemonetics for $551M. Pall has acquired in 3 different US states, and 4 countries. The Company’s most targeted sectors include life science (38%) and manufacturing (25%).
Join Mergr and gain access to Pall’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the manufacturing sector.
M&A Total Activity10
- M&A Buy Activity8
- M&A Sell Activity2
- Total Sectors Invested 5
- Total Countries Invested 4
- M&A Buy/Sell Connections 4